Bellefonte, PA, United States of America

Anthony P Burgard

This inventor holds 127 USPTO granted patents and 76 published patent applications, plus 11 CIPO patents and 33 EPO patents, primarily in Microbial Biotechnology (CPC class C12N15-52). Top assignees: Genomatica, Inc., The Penn State Research Foundation. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony P Burgard. Retrieved from https://idiyas.com/inventor/anthony-p-burgard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 127 

% Patents Active = 81.9

 

 

Average Co-Inventor Count = 3.9

ph-index = 18

Forward Citations = 992(Granted Patents)

Forward Citations (Not Self Cited) = 466(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • State College, PA (US) (2010 - 2011)
  • San Diego, PA (US) (2012)
  • Bellenfonte, PA (US) (2013)
  • Bellfonte, PA (US) (2017)
  • San Diego, CA (US) (2011 - 2018)
  • Bellefonte, CA (US) (2018)
  • Elizabeth, PA (US) (2020 - 2023)
  • Bellefonte, PA (US) (2010 - 2024)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Microorganisms
Fatty Alcohols
1,4-Butanediol
Adipate
Hexamethylenediamine
Reducing Equivalents
Carbon Flux
Biosynthesis
Methanol
Product Yields
Acetyl-CoA
Butadiene
127 patents (USPTO):Explore Patents

Title: Anthony P Burgard: Innovator Extraordinaire in Microbial Pathways

Introduction:

In the world of innovations and patents, Anthony P Burgard's name shines bright. As a resident of Bellefonte, Pennsylvania, Burgard has made significant contributions in the field of microbial pathways. With an impressive number of 119 patents to his name, his groundbreaking work continues to shape the biotechnology industry. This article explores Burgard's latest patents, career highlights, collaborations, and his invaluable contributions to the field.

Latest Patents:

Burgard's recent patents highlight his mastery of microbial processes and the production of organic compounds. One such patent, titled "Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol," introduces a non-naturally occurring microbial organism capable of efficiently utilizing methanol to enhance the availability of reducing equivalents. This advancement increases the production yield of organic compounds such as adipate, 6-aminocaproate, hexamethylenediamine, and caprolactam.

Another notable patent, "Microorganisms and methods for the production of caprolactone," focuses on the creation of non-naturally occurring microbial organisms with caprolactone pathways. By introducing exogenous nucleic acids encoding butadiene pathway enzymes, Burgard enables the production of caprolactone using these specialized organisms. This innovation opens doors for improved manufacturing processes and the utilization of caprolactone in various industries.

Career Highlights:

Throughout his career, Burgard has been associated with renowned companies dedicated to biotechnological advancements. His contributions have played a significant role in the success of these organizations. Notably, Burgard has worked with Genomatica, Inc., a leading bioengineering company known for its sustainable manufacturing processes. His expertise and groundbreaking patents have contributed to the company's overall progress.

Burgard has also collaborated with The Pennsylvania State Research Foundation, an institution focused on advancing knowledge and exploring new frontiers of research. His association with this esteemed foundation further highlights his commitment to pushing the boundaries of innovation.

Collaborations:

In his pursuit of innovation, Anthony P Burgard has collaborated with several esteemed professionals in the industry. Notably, he has worked alongside Mark Joseph Burk, a renowned researcher known for his expertise in microbial engineering. Their collaboration has resulted in numerous patents and publications that have advanced the field of bioengineering.

Priti Pharkya, another notable collaborator, has joined Burgard in his quest for microbial excellence. Pharkya's expertise in metabolic modeling complements Burgard's work in microbial pathways, resulting in synergistic advancements and groundbreaking discoveries.

Conclusion:

Anthony P Burgard's contributions to the field of microbial pathways through his inventions and patents are truly remarkable. With an impressive number of patents to his name, his work has opened new doors for the sustainable production of organic compounds. Collaboration with industry leaders and esteemed researchers further highlights the impact and importance of his work. As Burgard continues to innovate and inspire, the future of biotechnology looks brighter than ever.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…